Anthony Rossomando
Plus aucun poste en cours
Profil
Anthony Rossomando worked as a Director of Protein Sciences at Biogen, a Senior Director of Analytical Development at Alexion Pharmaceuticals, a Senior Director of siRNA Bioprocessing at Alnylam Pharmaceuticals, a Staff Scientist at Bayer Corp, a Vice President of Early Stage Development at Synageva BioPharma Corp, a Chief Technology Officer at NeuBase Therapeutics, and a Chief Process Development Officer at Pinetree Therapeutics.
He also served as a Vice President of Technology Operations at Anokion US, Inc. Rossomando earned a doctorate degree from the University of Virginia.
Anciens postes connus de Anthony Rossomando
| Sociétés | Poste | Fin |
|---|---|---|
Bayer Corp.
 Bayer Corp. Pharmaceuticals: MajorHealth Technology Bayer Corp. manufactures and markets pharmaceutical, healthcare, nutrition and materials products. The firm offers consumer care, diagnostics, diabetes and animal health products. It also provides material science products, which include coating, adhesive and sealant raw materials polycarbonates polyurethanes and thermoplastic polyurethane elastomers. The company was founded in 1973 and is based in Whippany, NJ. | Corporate Officer/Principal | - |
| ALNYLAM PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
| BIOGEN INC. | Corporate Officer/Principal | - |
| SYNAGEVA BIOPHARMA CORP | Corporate Officer/Principal | - |
| ALEXION PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Formation de Anthony Rossomando
| University of Virginia | Doctorate Degree |
Expériences
Fonctions occupées
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| BIOGEN INC. | Health Technology |
| ALNYLAM PHARMACEUTICALS, INC. | Health Technology |
| NEUBASE THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 5 |
|---|---|
Alexion Pharmaceuticals, Inc.
 Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA. | Health Technology |
Bayer Corp.
Bayer Corp. Pharmaceuticals: MajorHealth Technology Bayer Corp. manufactures and markets pharmaceutical, healthcare, nutrition and materials products. The firm offers consumer care, diagnostics, diabetes and animal health products. It also provides material science products, which include coating, adhesive and sealant raw materials polycarbonates polyurethanes and thermoplastic polyurethane elastomers. The company was founded in 1973 and is based in Whippany, NJ. | Health Technology |
Synageva BioPharma Corp.
 Synageva BioPharma Corp. BiotechnologyHealth Technology Synageva BioPharma Corp. is a biopharmaceutical company which focuses on the discovery, development, and commercialization of therapeutic products for patients with life-threatening rare diseases and high unmet medical need. The company is currently evaluating sebelipase alfa in global clinical trials for LAL Deficiency, a lysosomal storage disease associated with liver damage and accelerated atherosclerosis in children and adults, and in infants, premature death often before six months of age. Synageva BioPharma was founded in 1993 and is headquartered in Lexington, MA. | Health Technology |
Pinetree Therapeutics, Inc.
 Pinetree Therapeutics, Inc. BiotechnologyHealth Technology Pinetree Therapeutics, Inc. is a biotherapeutics company which engages in the development of antibodies to treat cancer. The company was founded by Ho-Juhn Song and is headquartered in Cambridge, MA. | Health Technology |
| Anokion US, Inc. |
